| Roberto Jafet Lopez Vega, MD | |
|
1900 Tebeau St, Waycross, GA 31501-6357 | |
| (201) 417-9656 | |
| Not Available |
| Full Name | Roberto Jafet Lopez Vega |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 1900 Tebeau St, Waycross, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891073482 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 73605 (Georgia) | Primary |
| 207R00000X | Internal Medicine | 25MA09541600 (New Jersey) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mayo Clinic Health System In Waycross | Waycross, GA | Hospital |
| Meadows Regional Medical Center | Vidalia, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cogent Healthcare Of Georgia Pc | 2961483607 | 255 |
| Hospital Physician Services - Southeast Professional Corporation | 5597774554 | 640 |
News Archive
Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy.
Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
› Verified 4 days ago
| Entity Name | 24 On Physicians Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912956251 PECOS PAC ID: 5698688141 Enrollment ID: O20031216000444 |
News Archive
Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy.
Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
› Verified 4 days ago
| Entity Name | Mayo Clinic Health System In Waycross, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154745982 PECOS PAC ID: 0042124919 Enrollment ID: O20040308000639 |
News Archive
Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy.
Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
› Verified 4 days ago
| Entity Name | Cogent Healthcare Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609827823 PECOS PAC ID: 2961483607 Enrollment ID: O20040527000856 |
News Archive
Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy.
Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
› Verified 4 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20060419000545 |
News Archive
Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy.
Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
› Verified 4 days ago
| Entity Name | Coffee County Hospitalist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811435464 PECOS PAC ID: 1153696117 Enrollment ID: O20171002002498 |
News Archive
Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy.
Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Roberto Jafet Lopez Vega, MD Po Box 173, Waycross, GA 31502 Ph: (201) 417-9656 | Roberto Jafet Lopez Vega, MD 1900 Tebeau St, Waycross, GA 31501-6357 Ph: (201) 417-9656 |
News Archive
Avinger, Inc., medical device manufacturer of innovative, multi-functional catheters for treating patients with peripheral artery disease, announced that it has successfully completed enrollment in its CONNECT clinical trial.
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy.
Hypertension Diagnostics, Inc., today announced that its non-invasive HDI/PulseWave CR-2000 Research System (CR-2000) has been selected for use in the Strategic Timing of AntiRetroviral Treatment (START) substudy on Arterial Elasticity that will examine blood vessel function and cardiovascular risk during HIV infection.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., announced that the U.S. Food and Drug Administration (FDA) approved EDARBYCLOR (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension to lower blood pressure in adults.
The American Telemedicine Association (ATA) has just announced its latest standard publication, 'A Blueprint for Telerehabilitation Guidelines,' which discusses the key administrative, clinical technical and ethical principles that should be considered in the course of providing telerehabilitation services. The purpose of these guidelines is to inform and assist practitioners in providing effective and safe services based on client needs, current empirical evidence, and available technologies.
› Verified 4 days ago
Jules M Nehmetallah, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 410 Darling Ave, Waycross, GA 31501 Phone: 913-338-6438 | |
Dr. James R. Kisselburg, M,D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1900 Tebeau Street, Waycross, GA 31501 Phone: 912-338-6438 Fax: 912-338-6439 |